PMID- 37975138
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231118
IS  - 2251-6581 (Print)
IS  - 2251-6581 (Electronic)
IS  - 2251-6581 (Linking)
VI  - 22
IP  - 2
DP  - 2023 Dec
TI  - Effect of Lifestyle Promotion in the PRECEDE-PROCEED model among pre-diabetic 
      adults based on PERSIAN cohort study: a randomized controlled trial study.
PG  - 1499-1509
LID - 10.1007/s40200-023-01273-7 [doi]
AB  - BACKGROUND: Diabetes is a chronic disease caused by impaired glucose metabolism. 
      This study aimed to design and evaluate the effect of a lifestyle promotion 
      program based on the PRECEDE-PROCEED model among pre-diabetic individuals. 
      METHODS: This randomized controlled trial evaluated the effect of a lifestyle 
      promotion program using the PRECEDE-PROCEED model among pre-diabetic individuals 
      in Hoveizeh city in 2019. The study collected information on the disease status 
      and risk factors associated with non-communicable conditions from the website of 
      Hoveizeh Cohort Study Center. The primary outcome of the study was the percentage 
      of glycated hemoglobin (HbA1c) with a three-month follow-up. RESULTS: A total of 
      240 individuals participated in the study. There was no significant difference in 
      anthropometric characteristics between the intervention and control groups 
      (P < 0.05). Initially, there was no significant difference in the mean HbA1c 
      between the intervention and control groups (P = 0.97). However, after three 
      months of intervention, a statistically significant difference was observed 
      (P > 0.001). The results indicated an increase in the mean quality of life in the 
      intervention group, but no significant difference was found between the two 
      groups or before and after the intervention within each group (P < 0.05). 
      CONCLUSION: The findings suggest that the PRECEDE-PROCEED model provides a 
      suitable framework for training pre-diabetic individuals and patients with type 2 
      diabetes mellitus (T2DM) to promote self-care behaviors. SUPPLEMENTARY 
      INFORMATION: The online version contains supplementary material available at 
      10.1007/s40200-023-01273-7.
CI  - (c) The Author(s), under exclusive licence to Tehran University of Medical Sciences 
      2023. Springer Nature or its licensor (e.g. a society or other partner) holds 
      exclusive rights to this article under a publishing agreement with the author(s) 
      or other rightsholder(s); author self-archiving of the accepted manuscript 
      version of this article is solely governed by the terms of such publishing 
      agreement and applicable law.
FAU - Meripour, Majed
AU  - Meripour M
AD  - Department of Health Education and Promotion, Faculty of Health, Ahvaz 
      Jundishapur University of Medical Sciences, Ahvaz, Iran. ROR: 
      https://ror.org/01rws6r75. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873
FAU - Mohamadian, Hashem
AU  - Mohamadian H
AD  - Department of Health Education and Promotion, Faculty of Health, Ahvaz 
      Jundishapur University of Medical Sciences, Ahvaz, Iran. ROR: 
      https://ror.org/01rws6r75. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873
FAU - Khafaie, Morteza Abdullatif
AU  - Khafaie MA
AUID- ORCID: 0000-0002-1651-3017
AD  - Department of Public Health, Faculty of Health, Ahvaz Jundishapur University of 
      Medical Sciences, Golestan St, Ahvaz, 15794_61357 Iran. ROR: 
      https://ror.org/01rws6r75. GRID: grid.411230.5. ISNI: 0000 0000 9296 6873
LA  - eng
PT  - Journal Article
DEP - 20230817
PL  - Switzerland
TA  - J Diabetes Metab Disord
JT  - Journal of diabetes and metabolic disorders
JID - 101590741
PMC - PMC10638267
OTO - NOTNLM
OT  - Diabetes Mellitus, type 2
OT  - Epidemiologic studies
OT  - Glucose metabolism Disorders
OT  - Glycated hemoglobin A
OT  - Lifestyle
OT  - Prediabetic state
COIS- Competing InterestsThe authors declare that they have no known competing 
      financial interests or personal relationships that could have appeared to 
      influence the work reported in this paper.
EDAT- 2023/11/17 15:30
MHDA- 2023/11/17 15:31
PMCR- 2024/08/17
CRDT- 2023/11/17 03:57
PHST- 2023/02/17 00:00 [received]
PHST- 2023/07/30 00:00 [accepted]
PHST- 2024/08/17 00:00 [pmc-release]
PHST- 2023/11/17 15:31 [medline]
PHST- 2023/11/17 15:30 [pubmed]
PHST- 2023/11/17 03:57 [entrez]
AID - 1273 [pii]
AID - 10.1007/s40200-023-01273-7 [doi]
PST - epublish
SO  - J Diabetes Metab Disord. 2023 Aug 17;22(2):1499-1509. doi: 
      10.1007/s40200-023-01273-7. eCollection 2023 Dec.